Literature DB >> 21795327

Epstein-Barr virus nuclear antigen 1 replication and segregation functions in nasopharyngeal carcinoma cell lines.

Nirojini Sivachandran1, Natalia N Thawe, Lori Frappier.   

Abstract

Nasopharyngeal carcinomas (NPC) are usually Epstein-Barr virus (EBV) positive, but, with the exception of C666-1 cells, these cells lose the EBV genomes when grown in culture. Maintenance of EBV requires the viral EBV nuclear antigen 1 (EBNA1) protein, which ensures the replication and mitotic segregation of the genomes through interactions with OriP. Here we compare the abilities of C666-1 and NPC cells that have lost EBV genomes to replicate and segregate OriP plasmids. We found that either cell line can replicate and maintain OriP plasmids for extended periods under conditions where low levels of EBNA1 are expressed but that high EBNA1 levels selectively interfered with mitotic segregation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21795327      PMCID: PMC3196394          DOI: 10.1128/JVI.05293-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

1.  Functional analyses of the EBNA1 origin DNA binding protein of Epstein-Barr virus.

Authors:  D F Ceccarelli; L Frappier
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  Updated Epstein-Barr virus (EBV) DNA sequence and analysis of a promoter for the BART (CST, BARF0) RNAs of EBV.

Authors:  Orlando de Jesus; Paul R Smith; Lindsay C Spender; Claudio Elgueta Karstegl; Hans Helmut Niller; Dolly Huang; Paul J Farrell
Journal:  J Gen Virol       Date:  2003-06       Impact factor: 3.891

3.  The Epstein-Barr virus nuclear protein 1 promoter active in type I latency is autoregulated.

Authors:  J Sample; E B Henson; C Sample
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

Review 4.  Replication licensing of the EBV oriP minichromosome.

Authors:  K Hirai; M Shirakata
Journal:  Curr Top Microbiol Immunol       Date:  2001       Impact factor: 4.291

Review 5.  Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments.

Authors:  Qian Tao; Anthony T C Chan
Journal:  Expert Rev Mol Med       Date:  2007-05-04       Impact factor: 5.600

6.  Autorepression of Epstein-Barr virus nuclear antigen 1 expression by inhibition of pre-mRNA processing.

Authors:  Mikio Yoshioka; Michelle M Crum; Jeffery T Sample
Journal:  J Virol       Date:  2007-12-12       Impact factor: 5.103

Review 7.  Epstein-Barr virus in the pathogenesis of NPC.

Authors:  Nancy Raab-Traub
Journal:  Semin Cancer Biol       Date:  2002-12       Impact factor: 15.707

8.  Protein profiling with Epstein-Barr nuclear antigen-1 reveals an interaction with the herpesvirus-associated ubiquitin-specific protease HAUSP/USP7.

Authors:  Melissa N Holowaty; Mahel Zeghouf; Hong Wu; Judy Tellam; Vicki Athanasopoulos; Jack Greenblatt; Lori Frappier
Journal:  J Biol Chem       Date:  2003-06-03       Impact factor: 5.157

9.  Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification.

Authors:  Claire Shannon-Lowe; Emily Adland; Andrew I Bell; Henri-Jacques Delecluse; Alan B Rickinson; Martin Rowe
Journal:  J Virol       Date:  2009-05-13       Impact factor: 5.103

10.  Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies.

Authors:  Nirojini Sivachandran; Feroz Sarkari; Lori Frappier
Journal:  PLoS Pathog       Date:  2008-10-03       Impact factor: 6.823

View more
  9 in total

1.  Modelling the structure of full-length Epstein-Barr virus nuclear antigen 1.

Authors:  Mushtaq Hussain; Derek Gatherer; Joanna B Wilson
Journal:  Virus Genes       Date:  2014-07-11       Impact factor: 2.332

Review 2.  Understanding the interplay between host immunity and Epstein-Barr virus in NPC patients.

Authors:  Yong Shen; Suzhan Zhang; Ren Sun; Tingting Wu; Jing Qian
Journal:  Emerg Microbes Infect       Date:  2015-03-25       Impact factor: 7.163

3.  MicroRNA-152 Targets Phosphatase and Tensin Homolog to Inhibit Apoptosis and Promote Cell Migration of Nasopharyngeal Carcinoma Cells.

Authors:  Shunde Huang; Xiaohua Li; Haotu Zhu
Journal:  Med Sci Monit       Date:  2016-11-13

4.  Transcriptome-wide analysis of alternative RNA splicing events in Epstein-Barr virus-associated gastric carcinomas.

Authors:  Victoria E S Armero; Marie-Pier Tremblay; Andréa Allaire; Simon Boudreault; Camille Martenon-Brodeur; Cyntia Duval; Mathieu Durand; Elvy Lapointe; Philippe Thibault; Maude Tremblay-Létourneau; Jean-Pierre Perreault; Michelle S Scott; Martin Bisaillon
Journal:  PLoS One       Date:  2017-05-11       Impact factor: 3.240

5.  Latent Membrane Protein 1 Is a Novel Determinant of Epstein-Barr Virus Genome Persistence and Reactivation.

Authors:  Elizabeth A Caves; Rachel M Butch; Sarah A Cook; Laura R Wasil; Chen Chen; Yuanpu Peter Di; Nara Lee; Kathy H Y Shair
Journal:  mSphere       Date:  2017-11-08       Impact factor: 4.389

6.  Epstein-Barr Virus Nuclear Antigen 1 Recruits Cyclophilin A to Facilitate the Replication of Viral DNA Genome.

Authors:  Shuyu Xin; Shujuan Du; Lingzhi Liu; Yan Xie; Lielian Zuo; Jing Yang; Jingjin Hu; Wenxing Yue; Jing Zhang; Pengfei Cao; Fanxiu Zhu; Jianhong Lu
Journal:  Front Microbiol       Date:  2019-12-13       Impact factor: 5.640

7.  Molecular pathological study of the human nasopharyngeal carcinoma CNE3 cell line.

Authors:  Fei Liu; Wei Jiao; Xiang-Lan Mo; Jiao Lan; Rui-Ping Xiao; Xiang-Zhen Zhou; Zhen-Lu Huang; Xiao-Min Mo; Gang Li
Journal:  Oncol Lett       Date:  2013-08-05       Impact factor: 2.967

Review 8.  Epstein-Barr virus infection and persistence in nasopharyngeal epithelial cells.

Authors:  Chi Man Tsang; Wen Deng; Yim Ling Yip; Mu-Sheng Zeng; Kwok Wai Lo; Sai Wah Tsao
Journal:  Chin J Cancer       Date:  2014-09-16

9.  Lymphomas driven by Epstein-Barr virus nuclear antigen-1 (EBNA1) are dependant upon Mdm2.

Authors:  Sana AlQarni; Yazeed Al-Sheikh; Donald Campbell; Mark Drotar; Adele Hannigan; Shelagh Boyle; Pawel Herzyk; Andrew Kossenkov; Kate Armfield; Lauren Jamieson; Mariarca Bailo; Paul M Lieberman; Penelope Tsimbouri; Joanna B Wilson
Journal:  Oncogene       Date:  2018-04-25       Impact factor: 9.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.